3. Poliomyelitis is…
• an acute viral infection
• caused by an RNA virus.
• word means “ grey spinal cord inflammation”
• primarily an infection of the human
alimentary tract
• virus may infect the CNS in about 1 % of cases
• resulting in varying degrees of paralysis, and
possibly death.
4. Problem statement
• In the pre-vaccination era,
poliomyelitis was found in
all countries of the world.
• The extensive use of polio
vaccines since 1954
eliminated the disease in
developed countries.
• India has not reported any polio case since
January 2011, and has been declared polio-
free since 27th March 2014.
5. Agent factors
AGENT : poliovirus
• three serotypes 1,2 and 3.
• paralytic polio outbreaks
mostly due to type-1 virus.
• faeco-oral route transmission.
• can survive for long periods in the external
environment.
• rapidly inactivated by pasteurization, and a
variety of physical and chemical agents.
6.
7. Epidemiological Characteristics of
Polio Serotypes
• All types cause paralysis
• Type 1- Most frequent paralysis,
Highest epidemic potential,
During polio free last serotype to disappear
• Type 2- Rarely paralytic,
during polio free first serotype to disappear
• Type 3- Paralysis less frequent
Less epidemic potential, scattered cases
8. Reservoir of infection :
• Man is the only known reservoir of infection.
• Most infections are subclinical.
• Mild and subclinical infections play a
dominant role in the spread.
• There are no chronic carriers.
• No animal source has yet been demonstrated.
9. Infectious material :
• virus is found in the faeces and oro-pharyngeal
secretions of an infected person.
Period of communicability :
• The cases are most infectious 7 to 10 days
before and after onset of symptoms.
• virus is excreted for 2 to 3 weeks in the faeces,
sometimes as long as 3 to 4 months.
10. Host factors
AGE :
• occurs in all age groups,
• but children are more susceptible than adults.
• In India polio is essentially a disease of infancy
and childhood.
• The most vulnerable age is between 6 months
and 3 years
SEX :
• Sex differences 3 males to 1 female.
11. RISK FACTORS :
• Several provocative or risk factors have been
found.
• They include fatigue, trauma, IM injections
• operative procedures such as tonsillectomy
undertaken especially during epidemics of
polio
• administration of immunizing agents
particularly alum-containing DPT.
12. IMMUNITY :
• maternal antibodies - first 6 months of life.
• Immunity following infection is fairly solid
• infection with one type does not protect
completely against the other two types
• Type-2 virus appears to be the most effective
antigen.
13. Environmental factors
• more likely during the rainy season.
• In India during June to September.
• Environmental sources : contaminated water,
food and flies.
• virus survives for a long time in a cold
environment.
• Overcrowding and poor sanitation provide
opportunities for exposure to infection.
14. Mode of transmission
FAECAL—ORAL ROUTE :
• main route of spread.
• directly through contaminated fingers where
hygiene is poor
• indirectly through contaminated water, milk,
foods, flies and articles of daily use.
DROPLET INFECTION :
• Close personal contact with an infected person
facilitates droplet spread.
16. Clinical spectrum
one of the following responses may occur.
1. Inapparent (Subclinical) Infection
2. Abortive Polio Or Minor Illness
3. Non-paralytic Polio
4. Paralytic Polio
17. Clinical Outcome of Poliovirus Infections
Paralytic poliomyelitis
Abortive-Clinical illness, no paralysis
Asymptomatic infection
90-95%4-8%
0.1-1%
18. INAPPARENT (SUB-CLINICAL) INFECTION :
• in 91-96 % of infections .
• no presenting symptoms.
• Recognition only by virus isolation or rising
antibody titres.
19. ABORTIVE POLIO OR MINOR ILLNESS :
• 4 to 8 % of the infections.
• only a mild or self limiting illness due to
viraemia.
• The patient recovers quickly.
• The diagnosis cannot be made clinically.
20. NON-PARALYTIC POLIO :
• 1 % of all infections.
• The presenting features are stiffness and pain
in the neck and back.
• The disease lasts 2 to 10 days.
• Recovery is rapid.
• The disease is synonymous with aseptic
meningitis.
21. PARALYTIC POLIO :
• less than 1 % of
infections.
• virus invades CNS
and causes varying
degrees of
paralysis.
28. Vaccination
Immunization is the only effective in preventing
poliomyelitis.
• essential to immunize all infants by 6 months
of age to protect them against polio.
Two types of vaccines:
1. Inactivated (Salk) polio vaccine (IPV).
2. Oral (Sabin) polio vaccine (OPV).
• Both are safe and effective when used correctly.
29. Inactivated polio vaccine (IPV) (Salk)
• usually made from selected WPV (wild) strains
• administered by IM (preferred) or SC injection.
• refrigerated to ensure no loss of potency.
• Freezing avoided
• Available as a stand-alone or in combination.
30. initial course consists of 4 inoculations.
• 1st dose - given to infant @ 6 weeks old.
• The 1st 3 doses - @ intervals of 1-2 months
• 4th dose - 6-12 months after the 3rd dose.
31. Oral polio vaccine (OPV) (Sabin)
contains live attenuated virus (types 1,2 and 3).
• given as trivalent (tOPV) vaccine.
primary course of 3 doses @ 1 month intervals,
• zero dose to all children delivered in the hospital.
• 1st dose @ 6 weeks.
• complete vaccination before 6 months of age.
Bcoz most polio cases occur between 6 months
and 3 years.
One booster dose recommended 12 to 18 months
later.
32. • Dose = 2 drops or as stated on the
label.
• Vaccine be stored at -20 °C in a
deep freeze until used.
• hot water, hot milk or hot fluids
should be withheld for about half
an hour after the adm. of the
vaccine.
• However, Breast milk can be given
whenever the child is hungry.
33.
34. Vaccine Derived Polio-virus (VDPV)
• OPV is a safe vaccine
• on rare occasions adverse events
• OPV adverse events may occur Vaccine-
associated paralytic poliomyelitis (VAPP)
• occurs in both OPV recipients and their
unimmunized child contacts.
• most frequently associated with type 3 (sabin)
(60% of cases); followed by type 2 and type 1
35.
36. Indian Scenario
• In India vaccination against polio started in
1978. it was successful in covering around
40%.
• Universal immunization programme (UIP) was
launched 1995
• Pulse polio immunization programme along
with UIP
37. Strategies for polio eradication in India
• PPI days every year until poliomyelitis is
eradicated.
• Sustain high levels of routine immunization
coverage.
• Monitor OPV coverage at district level and
below.
• Improve surveillance - detecting all cases of AFP
due to polio and non-polio reason.
• Rapid case investigation, including the
collection of stool samples for virus isolation
38. • follow-up of all cases of AFP at 60 days to
check for residual paralysis.
• outbreak control for cases confirmed or
suspected to stop transmission.
• Even a single case is treated as an outbreak.
• preventive measures initiated within 48 hr of
notification of the case.
• complete and timely reporting of cases is
important element for the eradication.
• Reporting of all cases of AFP in children under
15 years of age is mandatory.
39. Mopping Up
• Mopping up activities are usually the last
stage in polio eradication.
"mopping up" involves
• door to door immunization in high-risk
districts, where wild polio virus is known or
suspected to be still circulating.
• This strategy is being implemented in India.
40. Pulse Polio Immunization
GOI conducted -
• the first round of PPI consisting of two
immunization days on…
• 9th December 1995 and 20th January 1996.
• The 1st PPI targeted all children under 3 years
irrespective of their immunization status.
• Later on, as recommended by WHO, the age
group increased from under 3 to under 5
years.
41. Mass Immunization campaign
(Pulse Polio Immunization)
Pulse meaning -
• Sudden, Simultaneous, mass administration of
OPV…
• on a single day- to all children 0-5 years of age
• …irrespective of their previous polio
vaccination status
• It is additional to routine immunization
• Also known as NIDs (National Immunization
Days)
42. • Two rounds 4 -6 wk apart during low
transmission season of polio (between
November to February)
• In India, the peak transmission is from June to
September.
• The dose of OPV during PPIs are EXTRA doses
• they DO NOT replace the doses during routine
immunization.
43. Several strategies utilized:
• Development of monovalent OPV. (mOPV1
and mOPV3)
• deployment of additional personel to assist
• social mobilization to reaching population
groups missed previous
• mobile teams to vaccinate children at transit
points (railway and bus stations)
• increased engagement and accountability of
political leaders and of health staff at all
levels.
45. last case of polio in the country
• was reported from Howrah of West Bengal
dated 13th January 2011.
• Thereafter no polio case has been reported in
the country.
• On 27th March 2014, India was declared as
non-endemic country for polio.
46. Gujarat- Last Case in 2007
Source-polio_frequently_asked_statistics_02_apr2015
47. Do Boond Zindagi ki ……….
Follow us:
Facebook:
• https://fb.me/SwasthavrittaGAAC
Youtube:
• https://www.youtube.com/channel/UCPvrBlyheQcqwBXs1egxzWw
SlideShare:
• https://www.slideshare.net/SwasthvrittaAkhandan